Abstract
Aim: The most frequent finding associated with incidental fluorodeoxyglucose (FDG) uptake in sellar region in oncologic F-18 FDG PET/CT is adenoma. However, reports of metastatic involvement exist. We investigated the clinical significance of incidental FDG uptake in this region. Materials & method: 34 patients with several primary tumors who were referred for staging, restaging or treatment response via F-18 FDG PET/CT were included. Images were reviewed and patients with significant FDG uptake in the sellar region were referred. Results: Mean lesion diameter was 11.9 ± 4.9 mm and mean standardized uptake value was 8.2 ± 6.1. Thirteen patients underwent MRI, and the others underwent follow-up F-18 FDG PET/CT. MRI revealed metastatic involvement in nine patients and macro- or micro-adenoma in four. Metastatic patients also had other lesions, yet management did not change. Conclusion: FDG accumulation in the sellar region might be associated with metastasis or adenoma. However, it did not change management. Future studies are warranted.
Cite
CITATION STYLE
Koç, Z. P., Kara, P. Ö., Sezer, E., Eser, K., & Özgür, A. (2019). The Clinical Impact of Incidental Sellar Uptake on F-18 FDG PET/CT. International Journal of Endocrine Oncology, 6(2). https://doi.org/10.2217/ije-2018-0004
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.